glp 1 google scholar GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Frontiers | Mechanisms of action
Description
Antidiabetic activities of entagenic acid in type 2 diabetic db/db mice and L6 myotubes via AMPK/GLUT4 pathway
Theyve been around to help people manage type 2 diabetes by mimicking the activity of the GLP-1 hormone
Health experts attribute the rise in childhood obesity to unhealthy diets and increased screen addiction
1.2 Safety considerations and the limits of the GLP-1 analogy The success of GLP-1 receptor agonists should not obscure legitimate safety considerations associated with chronic peptide therapy
